EFIL BioScience
PrivateLast Round
Early Funding
Oct 30, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
EFIL BioScience operates in Healthcare & Life Sciences and is based in South Korea. Its latest recorded funding round was a Seed round in October 2021.
EFIL BioScience is a biotechnology company that develops therapeutic products designed to treat severe obesity and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EFIL BioScience Comparables
Compare EFIL BioScience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ConSynance Therapeutics | 72% | |
| D&D Pharmatech | 67% | |
| Pfizer | 64% |
For institutional investors. Book with your work email.
EFIL BioScience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Oct 30, 2025 | ||||
| Seed | Oct 1, 2021 |
For institutional investors. Book with your work email.
EFIL BioScience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Laplace Partners | Seed |
| Tech Incubator Program for Startups | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 13, 2026
Monthly visitors increased 293% MoM, reaching 758.
- Aug 21, 2026
Monthly visitors grew 68% MoM, reaching 1.2K.
For institutional investors. Book with your work email.
EFIL BioScience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about EFIL BioScience's valuation, stock price, and market status.
Is EFIL BioScience a public or private company?
EFIL BioScience is a private company.
What is the current stock price of EFIL BioScience?
EFIL BioScience is a private company, so its shares have no public market price. Caplight tracks EFIL BioScience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is EFIL BioScience worth (valuation)?
Valuation information for EFIL BioScience is not publicly available.
Can I buy EFIL BioScience stock?
EFIL BioScience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was EFIL BioScience's last funding round?
EFIL BioScience's most recent funding round was Early Funding on October 30, 2025.
Who are the main investors in EFIL BioScience?
Key investors in EFIL BioScience include Laplace Partners, Tech Incubator Program for Startups.
Will EFIL BioScience IPO soon?
No public IPO plans have been announced for EFIL BioScience.
How can I track EFIL BioScience secondary market activity?
Caplight tracks bids, offers, and trades in EFIL BioScience's shares on secondary markets.